Toma Pfeffer, CEO of Bayer UK and Ireland, zeroed in on the structural problem: Most healthcare systems were structurally incentivized to look no further than the next 12 months. His call for collaboration on reimbursement models reflects Bayers bet that the winners in cell and gene therapy will be those with the patience and capital to design trials that anticipate health technology assessment endpoints from the start
doi: 10.1016/j.bmcl.2013.05.022 25 WenDWangXHeYHaoXHuangWZhouHet al
For sharps disposal guidance, refer to the US Food and Drug Administration (FDA) Safe Sharps Disposal resource at www.fda.gov
For questions about specific products, substances, and methods, you can also contact USADAs Drug Reference Line at [email protected] or call (719) 785-2000, option 2.
The safety and efficacy of fat dissolving injections can vary depending on the treated areas and the method used, and individual results may differ, highlighting the need for thorough consultation and medical supervision
You get injection tracking, food logging, hydration monitoring, side effect management, and progress visualization all working seamlessly together
